ID   GLYG2_HUMAN             Reviewed;         501 AA.
AC   O15488; B7WNN6; O15485; O15486; O15487; O15489; O15490;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Glycogenin-2;
DE            Short=GN-2;
DE            Short=GN2;
DE            EC=2.4.1.186;
GN   Name=GYG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Liver;
RX   PubMed=9346895; DOI=10.1074/jbc.272.44.27589;
RA   Mu J., Skurat A.V., Roach P.J.;
RT   "Glycogenin-2, a novel self-glucosylating protein involved in liver
RT   glycogen biosynthesis.";
RL   J. Biol. Chem. 272:27589-27597(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10721716; DOI=10.1016/S0378-1119(99)00520-X;
RA   Zhai L., Mu J., Zong H., DePaoli-Roach A.A., Roach P.J.;
RT   "Structure and chromosomal localization of the human glycogenin-2 gene
RT   GYG2.";
RL   Gene 242:229-235(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA), AND VARIANT
RP   ARG-313.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION, AND GLYCOSYLATION AT TYR-228.
RX   PubMed=9857012; DOI=10.1074/jbc.273.52.34850;
RA   Mu J., Roach P.J.;
RT   "Characterization of human glycogenin-2, a self-glucosylating
RT   initiator of liver glycogen metabolism.";
RL   J. Biol. Chem. 273:34850-34856(1998).
RN   [6]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line
RT   protein expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368; SER-399 AND
RP   SER-459, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANT ARG-194.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Self-glucosylates, via an inter-subunit mechanism, to
CC       form an oligosaccharide primer that serves as substrate for
CC       glycogen synthase.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucose + glycogenin = UDP +
CC       alpha-D-glucosylglycogenin.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Divalent metal ions. Required for self-glucosylation.
CC       Manganese is the most effective.;
CC   -!- PATHWAY: Glycan biosynthesis; glycogen biosynthesis.
CC   -!- SUBUNIT: Homodimer, tightly complexed to glycogen synthase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Alpha;
CC         IsoId=O15488-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=O15488-2; Sequence=VSP_001770;
CC       Name=Gamma;
CC         IsoId=O15488-3; Sequence=VSP_001771;
CC       Name=Delta;
CC         IsoId=O15488-4; Sequence=VSP_001772;
CC       Name=Epsilon;
CC         IsoId=O15488-5; Sequence=VSP_001773;
CC       Name=Zeta;
CC         IsoId=O15488-6; Sequence=VSP_001774;
CC   -!- TISSUE SPECIFICITY: Expressed preferentially in liver, heart, and
CC       pancreas.
CC   -!- PTM: Self-glycosylated by the transfer of glucose residues from
CC       UDP-glucose to itself, forming an alpha-1,4-glycan of around 10
CC       residues attached to Tyr-228. {ECO:0000269|PubMed:9857012}.
CC   -!- MASS SPECTROMETRY: Mass=55211.89; Method=MALDI; Range=1-501;
CC       Evidence={ECO:0000269|PubMed:11840567};
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 8 family.
CC       Glycogenin subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U94362; AAB84377.1; -; mRNA.
DR   EMBL; U94363; AAB84378.1; -; mRNA.
DR   EMBL; U94364; AAB84379.1; -; mRNA.
DR   EMBL; U94357; AAB84373.1; -; mRNA.
DR   EMBL; U94358; AAB84374.1; -; mRNA.
DR   EMBL; U94360; AAB84375.1; -; mRNA.
DR   EMBL; U94361; AAB84376.1; -; mRNA.
DR   EMBL; AF179624; AAF61855.1; -; Genomic_DNA.
DR   EMBL; AF179615; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179616; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179617; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179618; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179619; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179620; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179621; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179622; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AF179623; AAF61855.1; JOINED; Genomic_DNA.
DR   EMBL; AC138085; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC023152; AAH23152.1; -; mRNA.
DR   CCDS; CCDS14121.1; -. [O15488-1]
DR   CCDS; CCDS48074.1; -. [O15488-2]
DR   CCDS; CCDS55365.1; -. [O15488-4]
DR   RefSeq; NP_001073324.1; NM_001079855.1. [O15488-2]
DR   RefSeq; NP_001171631.1; NM_001184702.1.
DR   RefSeq; NP_001171632.1; NM_001184703.1. [O15488-4]
DR   RefSeq; NP_001171633.1; NM_001184704.1.
DR   RefSeq; NP_003909.2; NM_003918.2. [O15488-1]
DR   RefSeq; XP_011543902.1; XM_011545600.2. [O15488-2]
DR   RefSeq; XP_016885416.1; XM_017029927.1. [O15488-1]
DR   RefSeq; XP_016885417.1; XM_017029928.1. [O15488-1]
DR   UniGene; Hs.567381; -.
DR   UniGene; Hs.701629; -.
DR   PDB; 4UEG; X-ray; 1.93 A; A/B=35-300.
DR   PDBsum; 4UEG; -.
DR   ProteinModelPortal; O15488; -.
DR   SMR; O15488; -.
DR   BioGrid; 114422; 16.
DR   IntAct; O15488; 3.
DR   MINT; MINT-5003813; -.
DR   STRING; 9606.ENSP00000370555; -.
DR   CAZy; GT8; Glycosyltransferase Family 8.
DR   iPTMnet; O15488; -.
DR   PhosphoSitePlus; O15488; -.
DR   BioMuta; GYG2; -.
DR   EPD; O15488; -.
DR   MaxQB; O15488; -.
DR   PaxDb; O15488; -.
DR   PeptideAtlas; O15488; -.
DR   PRIDE; O15488; -.
DR   DNASU; 8908; -.
DR   Ensembl; ENST00000353656; ENSP00000487294; ENSG00000056998. [O15488-4]
DR   Ensembl; ENST00000381163; ENSP00000370555; ENSG00000056998. [O15488-1]
DR   Ensembl; ENST00000398806; ENSP00000381786; ENSG00000056998. [O15488-2]
DR   GeneID; 8908; -.
DR   KEGG; hsa:8908; -.
DR   UCSC; uc004cqs.2; human. [O15488-1]
DR   CTD; 8908; -.
DR   DisGeNET; 8908; -.
DR   GeneCards; GYG2; -.
DR   H-InvDB; HIX0016632; -.
DR   H-InvDB; HIX0025849; -.
DR   HGNC; HGNC:4700; GYG2.
DR   HPA; HPA005495; -.
DR   HPA; HPA064686; -.
DR   MIM; 300198; gene.
DR   neXtProt; NX_O15488; -.
DR   OpenTargets; ENSG00000056998; -.
DR   PharmGKB; PA29078; -.
DR   eggNOG; KOG1950; Eukaryota.
DR   eggNOG; COG5597; LUCA.
DR   GeneTree; ENSGT00390000004721; -.
DR   HOGENOM; HOG000008282; -.
DR   HOVERGEN; HBG000681; -.
DR   InParanoid; O15488; -.
DR   KO; K00750; -.
DR   OMA; NTAYTYS; -.
DR   OrthoDB; EOG091G09E1; -.
DR   PhylomeDB; O15488; -.
DR   TreeFam; TF312839; -.
DR   BioCyc; MetaCyc:HS00703-MONOMER; -.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-3858516; Glycogen storage disease type 0 (liver GYS2).
DR   Reactome; R-HSA-3878781; Glycogen storage disease type IV (GBE1).
DR   Reactome; R-HSA-5357572; Lysosomal glycogen catabolism.
DR   Reactome; R-HSA-5357609; Glycogen storage disease type II (GAA).
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   UniPathway; UPA00164; -.
DR   ChiTaRS; GYG2; human.
DR   GenomeRNAi; 8908; -.
DR   PRO; PR:O15488; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000056998; -.
DR   CleanEx; HS_GYG2; -.
DR   ExpressionAtlas; O15488; baseline and differential.
DR   Genevisible; O15488; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0008466; F:glycogenin glucosyltransferase activity; EXP:Reactome.
DR   GO; GO:0005978; P:glycogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0005980; P:glycogen catabolic process; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR002495; Glyco_trans_8.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF01501; Glyco_transf_8; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Glycogen biosynthesis; Glycoprotein; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    501       Glycogenin-2.
FT                                /FTId=PRO_0000215180.
FT   ACT_SITE    119    119       {ECO:0000250}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     399    399       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     459    459       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    228    228       O-linked (Glc...) tyrosine.
FT                                {ECO:0000269|PubMed:9857012}.
FT   VAR_SEQ       3     42       Missing (in isoform Gamma).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001771.
FT   VAR_SEQ       3     33       Missing (in isoform Beta).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001770.
FT   VAR_SEQ     378    448       Missing (in isoform Delta).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001772.
FT   VAR_SEQ     407    501       Missing (in isoform Epsilon).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001773.
FT   VAR_SEQ     413    448       Missing (in isoform Zeta). {ECO:0000305}.
FT                                /FTId=VSP_001774.
FT   VARIANT       7      7       H -> Y (in dbSNP:rs11797037).
FT                                /FTId=VAR_053110.
FT   VARIANT     194    194       G -> R (found in a renal cell carcinoma
FT                                case; somatic mutation;
FT                                dbSNP:rs200824650).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064717.
FT   VARIANT     270    270       A -> V (in dbSNP:rs2306734).
FT                                /FTId=VAR_010401.
FT   VARIANT     313    313       H -> R (in dbSNP:rs2306735).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024457.
FT   VARIANT     373    373       R -> C (in dbSNP:rs17330993).
FT                                /FTId=VAR_031224.
FT   MUTAGEN     228    228       Y->F: Loss of activity.
FT   MUTAGEN     230    230       Y->F: No loss of activity.
FT   CONFLICT    413    413       Missing (in Ref. 1; AAB84378).
FT                                {ECO:0000305}.
FT   CONFLICT    462    464       EKV -> AGI (in Ref. 1; AAB84376).
FT                                {ECO:0000305}.
FT   STRAND       37     43       {ECO:0000244|PDB:4UEG}.
FT   TURN         46     48       {ECO:0000244|PDB:4UEG}.
FT   HELIX        49     61       {ECO:0000244|PDB:4UEG}.
FT   STRAND       66     72       {ECO:0000244|PDB:4UEG}.
FT   HELIX        78     84       {ECO:0000244|PDB:4UEG}.
FT   TURN         85     87       {ECO:0000244|PDB:4UEG}.
FT   STRAND       89     93       {ECO:0000244|PDB:4UEG}.
FT   HELIX       101    109       {ECO:0000244|PDB:4UEG}.
FT   HELIX       111    113       {ECO:0000244|PDB:4UEG}.
FT   HELIX       114    120       {ECO:0000244|PDB:4UEG}.
FT   HELIX       121    124       {ECO:0000244|PDB:4UEG}.
FT   STRAND      128    134       {ECO:0000244|PDB:4UEG}.
FT   STRAND      138    140       {ECO:0000244|PDB:4UEG}.
FT   HELIX       145    149       {ECO:0000244|PDB:4UEG}.
FT   STRAND      152    157       {ECO:0000244|PDB:4UEG}.
FT   STRAND      159    161       {ECO:0000244|PDB:4UEG}.
FT   STRAND      164    172       {ECO:0000244|PDB:4UEG}.
FT   HELIX       176    189       {ECO:0000244|PDB:4UEG}.
FT   HELIX       196    203       {ECO:0000244|PDB:4UEG}.
FT   TURN        204    209       {ECO:0000244|PDB:4UEG}.
FT   HELIX       212    214       {ECO:0000244|PDB:4UEG}.
FT   HELIX       218    220       {ECO:0000244|PDB:4UEG}.
FT   TURN        225    227       {ECO:0000244|PDB:4UEG}.
FT   HELIX       232    237       {ECO:0000244|PDB:4UEG}.
FT   HELIX       238    240       {ECO:0000244|PDB:4UEG}.
FT   STRAND      242    245       {ECO:0000244|PDB:4UEG}.
FT   HELIX       252    254       {ECO:0000244|PDB:4UEG}.
FT   HELIX       277    290       {ECO:0000244|PDB:4UEG}.
FT   HELIX       292    298       {ECO:0000244|PDB:4UEG}.
SQ   SEQUENCE   501 AA;  55184 MW;  8488A09D6E564693 CRC64;
     MSETEFHHGA QAGLELLRSS NSPTSASQSA GMTVTDQAFV TLATNDIYCQ GALVLGQSLR
     RHRLTRKLVV LITPQVSSLL RVILSKVFDE VIEVNLIDSA DYIHLAFLKR PELGLTLTKL
     HCWTLTHYSK CVFLDADTLV LSNVDELFDR GEFSAAPDPG WPDCFNSGVF VFQPSLHTHK
     LLLQHAMEHG SFDGADQGLL NSFFRNWSTT DIHKHLPFIY NLSSNTMYTY SPAFKQFGSS
     AKVVHFLGSM KPWNYKYNPQ SGSVLEQGSA SSSQHQAAFL HLWWTVYQNN VLPLYKSVQA
     GEARASPGHT LCHSDVGGPC ADSASGVGEP CENSTPSAGV PCANSPLGSN QPAQGLPEPT
     QIVDETLSLP EGRRSEDMIA CPETETPAVI TCDPLSQPSP QPADFTETET ILQPANKVES
     VSSEETFEPS QELPAEALRD PSLQDALEVD LAVSVSQISI EEKVKELSPE EERRKWEEGR
     IDYMGKDAFA RIQEKLDRFL Q
//
